The effect of acid reduction with a proton pump inhibitor on the pharmacokinetics of lopinavir or ritonavir in HIV-infected patients on lopinavir/ritonavir-based therapy.

Journal of clinical pharmacology

Volumn 50, Issue 9, 2010, Pages 1050-1055

  Overton, Edgar T ^a   Tschampa, Jean M ^b   Klebert, Michael ^b   Royal, Mike ^b   Rodriguez, Mark ^b   Spitz, Teresa ^b   Kim, GeYoul ^b   Mondy, Kristin E ^b   Acosta, Edward P ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; LOPINAVIR; OMEPRAZOLE; PROTON PUMP INHIBITOR; PYRIMIDINONE DERIVATIVE; RITONAVIR;

ADULT; ARTICLE; DRUG INTERACTION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DRUG INTERACTIONS; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROTON PUMP INHIBITORS; PYRIMIDINONES; RITONAVIR; YOUNG ADULT;

MLCS; MLOWN;

EID: 79952276420     PISSN: None     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270009357431     Document Type: Article

References (0)